US

Matthew J Shaffer

This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew J Shaffer. Retrieved from https://idiyas.com/inventor/matthew-j-shaffer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Matthew J Shaffer: Innovator in Pharmaceutical Compositions

Introduction

Matthew J Shaffer is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on high drug loadings of medium chain triglycerides. His work aims to address critical health conditions, including Alzheimer's disease.

Latest Patents

Matthew J Shaffer holds a notable patent titled "Pharmaceutical Compositions Having High Drug Loadings Of Medium Chain Triglycerides And Methods Related Thereto." This invention relates to high drug load compositions of medium chain triglycerides (MCT) and methods for treatment with such compositions. The goal is to elevate ketone body concentrations effectively to treat conditions associated with reduced neuronal metabolism.

Career Highlights

Matthew J Shaffer is currently associated with Cerecin Inc., a company dedicated to advancing treatments for neurological conditions. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the field.

Collaborations

Matthew collaborates with talented individuals such as Aaron M Badenoch and Taryn Boivin, contributing to innovative projects within the pharmaceutical sector.

Conclusion

Matthew J Shaffer's work in pharmaceutical compositions showcases his commitment to improving health outcomes for individuals with neurological conditions. His innovative approach and collaboration with skilled professionals highlight his significant role in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…